Back to search
FDAFDA · Food and drugs·Recall number D-0370-2021

Burro en Primavera, 2 capsules, UPC 638632431055

Published May 12, 2021 · Recall initiated: March 31, 2021

Summary

FDA records drug Class II recall D-0370-2021, published May 12, 2021 and initiated March 31, 2021. Recalling firm: QMart; Status: Ongoing; Reported quantity: 500 boxes; Lot: All. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
QMart
Distributor
USA Nationwide
UPC
638632431055
Lot
All
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Burro en Primavera, 2 capsules, UPC 638632431055 recalled?

Yes. FDA published recall D-0370-2021 on May 12, 2021. Reported hazard: Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release

How do I know if my unit is part of the recall?

Compare your product details with the notice. UPC: 638632431055.